Posts by Henry Shikani
Immunotherapy has emerged as one of the most promising mechanisms to combat diseases like cancer and microbial infections. Since 2000, multiple antibody drugs have reached blockbuster status, including …
is a Technical Specialist at Finnegan who focuses his practice on patent prosecution, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and patent litigation in the chemical, pharmaceutical, medical device, and biotechnology fields. His experience includes assisting with Abbreviated New Drug Application (ANDA) litigations under the Hatch-Waxman Act, inter partes review (IPR) trials, and interference proceedings.
For more information, or to contact Dr. Shikani, please visit his Firm Profile Page